◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SNN

Smith & Nephew SNATS Inc (SNN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-08-04

Smith & Nephew SNATS Inc (SNN) operates in the MEDICAL DEVICES industry and is headquartered in Watford, United Kingdom with about 17,000 employees. Its market capitalization is roughly $12 billion. In the fiscal year ended 2025-12-31, SNN reported $6.2B in revenue and $625M in net income.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

Interactive charts & full statements → Open the SNN valuation workbench →

SNN Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2025-12-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$6.2B	$6.2B	$5.8B	$5.5B	$5.2B	$5.2B	$4.6B	$5.1B	$4.9B	$4.8B	$4.7B	$4.6B	$4.6B	$4.4B	$4.1B	$4.3B	$4.0B	$3.8B	$3.8B	$3.4B	$2.8B
Gross Profit	$4.2B	$4.2B	$4.1B	$3.9B	$3.7B	$3.7B	$3.2B	$3.8B	$3.6B	$3.5B	$3.4B	$3.5B	$3.5B	$3.3B	$3.1B	$3.1B	$2.9B	$2.7B	$2.7B	$2.4B	$2.0B
Gross Margin %	68.2%	68.2%	70.2%	70.2%	71.0%	71.0%	69.7%	74.1%	73.5%	73.8%	72.8%	75.3%	75.6%	75.1%	74.1%	73.3%	74.0%	72.7%	71.7%	70.5%	72.3%
Operating Income (EBIT)	$794M	$794M	$657M	$425M	$450M	$593M	$295M	$815M	$863M	$934M	$801M	$628M	$749M	$810M	$846M	$862M	$920M	$723M	$630M	$493M	$537M
Operating Margin %	12.9%	12.9%	11.3%	7.7%	8.6%	11.4%	6.5%	15.9%	17.6%	19.6%	17.2%	13.6%	16.2%	18.6%	20.4%	20.2%	23.2%	19.2%	16.6%	14.6%	19.3%
Net Income	$625M	$625M	$412M	$263M	$223M	$524M	$448M	$600M	$663M	$767M	$784M	$410M	$501M	$556M	$729M	$582M	$615M	$472M	$377M	$316M	$745M
Net Margin %	10.1%	10.1%	7.1%	4.7%	4.3%	10.1%	9.8%	11.7%	13.5%	16.1%	16.8%	8.8%	10.8%	12.8%	17.6%	13.6%	15.5%	12.5%	9.9%	9.4%	26.8%
EBITDA	$1.3B	$1.3B	$1.3B	$1.2B	$1.1B	$1.2B	$927M	$1.4B	$1.4B	$1.3B	$1.3B	$1.2B	$1.3B	$1.2B	$1.2B	$1.2B	$1.2B	$1.0B	$910M	$721M	$703M
Earnings Per Share (EPS)	$1.43	$1.43	$0.94	$1.20	$0.51	$1.19	$1.02	$1.37	$1.52	$1.75	$1.76	$0.94	$1.11	$1.23	$1.62	$1.30	$1.38	$1.07	$0.85	$0.68	$1.58
Shares Outstanding (M)	436M	436M	438M	218M	438M	439M	438M	438M	438M	438M	446M	436M	450M	453M	450M	448M	444M	443M	445M	464M	472M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2025-12-31	2025-06-30	2024-12-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Total Revenue	$3.2B	$3.0B	$3.0B	$2.8B	$1.4B	$2.8B	$1.4B	$2.7B
Gross Profit	$2.1B	$2.1B	$2.1B	$2.0B	$987M	$2.0B	$997M	$1.9B
Gross Margin %	66.1%	70.6%	70.6%	69.8%	69.8%	70.9%	70.8%	69.4%
Operating Income (EBIT)	$365M	$429M	$329M	$328M	$164M	$150M	$204M	$275M
Operating Margin %	11.4%	14.5%	11.0%	11.6%	11.6%	5.3%	14.5%	10.1%
Net Income	$332M	$293M	$198M	$214M	$107M	$91M	$46M	$172M
Net Margin %	10.4%	9.9%	6.6%	7.6%	7.6%	3.2%	3.2%	6.3%
EBITDA	$634M	$702M	$734M	$601M	$260M	$615M	$272M	$561M
Earnings Per Share (EPS)	$0.76	$0.67	$0.45	$0.49	$0.12	$0.10	$0.05	$0.40
Shares Outstanding (M)	436M	440M	440M	437M	873M	873M	873M	435M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNN Free Cash Flow History

Cash flow	TTM → 2025-12-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.3B	$1.3B	$987M	$608M	$468M	$877M	$935M	$1.2B	$931M	$1.1B	$849M	$1.0B	$683M	$867M	$902M	$842M	$859M	$719M	$566M	$424M	$352M
Capital Expenditures (CapEx)	$433M	$433M	$381M	$427M	$358M	$408M	$443M	$408M	$347M	$376M	$320M	$303M	$298M	$242M	$265M	$321M	$315M	$318M	$289M	$194M	$222M
Free Cash Flow (FCF)	$852M	$852M	$606M	$181M	$110M	$469M	$492M	$760M	$584M	$714M	$529M	$727M	$385M	$625M	$637M	$521M	$544M	$401M	$277M	$230M	$130M
FCF Margin %	13.8%	13.8%	10.4%	3.3%	2.1%	9.0%	10.8%	14.8%	11.9%	15.0%	11.3%	15.7%	8.3%	14.4%	15.4%	12.2%	13.7%	10.6%	7.3%	6.8%	4.7%
Dividends Paid	$330M	$330M	$327M	$327M	$327M	$329M	$328M	$318M	$321M	$269M	$279M	$272M	$250M	$239M	$186M	$146M	$132M	$120M	$109M	$105M	$96M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2025-12-31	2025-06-30	2024-12-31	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Cash from Operations (CFO)	$889M	$396M	$749M	$238M	$119M	$495M	$248M	$56M
Capital Expenditures (CapEx)	$294M	$139M	$209M	$172M	$86M	$260M	$130M	$84M
Free Cash Flow (FCF)	$595M	$257M	$540M	$66M	$33M	$235M	$118M	($27M)
FCF Margin %	18.6%	8.7%	18.1%	2.3%	2.3%	8.3%	8.3%	-1.0%
Dividends Paid	$128M	$202M	$125M	$202M	$101M	$126M	$63M	$100M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNN Balance Sheet History

Balance sheet	2025-12-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$10.5B	$10.5B	$10.4B	$10.0B	$10.0B	$10.9B	$11.0B	$9.3B	$8.1B	$7.9B	$7.3B	$7.2B	$7.3B	$5.8B	$5.6B	$4.7B	$4.7B	$4.6B	$4.5B	$4.5B	$3.2B
Cash & Cash Equivalents	$557M	$557M	$619M	$302M	$350M	$1.3B	$1.8B	$277M	$365M	$169M	$100M	$120M	$93M	$137M	$178M	$184M	$207M	$192M	$145M	$170M	$346M
Total Liabilities	$5.2B	$5.2B	$5.1B	$4.8B	$4.7B	$5.4B	$5.7B	$4.2B	$3.2B	$3.2B	$3.4B	$3.2B	$3.3B	$1.8B	$1.8B	$1.6B	$2.0B	$2.4B	$2.8B	$2.6B	$1.1B
Total Debt (Short + Long-Term)	$3.2B	$3.2B	$3.2B	$2.9B	$2.7B	$3.2B	$3.5B	$1.9B	$1.5B	$1.5B	$1.6B	$1.5B	$1.7B	$391M	$468M	$322M	$699M	$1.1B	$1.5B	$1.5B	$134M
Total Shareholders' Equity	$5.3B	$5.3B	$5.3B	$5.2B	$5.3B	$5.6B	$5.3B	$5.1B	$4.9B	$4.6B	$4.0B	$4.0B	$4.0B	$4.0B	$3.9B	$3.2B	$2.8B	$2.2B	$1.7B	$1.8B	$2.2B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SNN viewer.

SNN Metric Deep Dives

Other Companies in MEDICAL DEVICES

PHG · Koninklijke Philips NV ADR — $24 billion
PEN · Penumbra Inc — $13 billion
BIO · Bio-Rad Laboratories Inc — $10 billion
GMED · Globus Medical — $10 billion
BIO.B · Bio-Rad Laboratories Inc — $10 billion
GKOS · Glaukos Corp — $10 billion
BRKR · Bruker Corporation — $9 billion
HAE · Haemonetics Corporation — $5 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← SNK All “S” companies SNNP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.